Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
809.00    1.00 (0.12%)
Bid:
808.00
Ask:
810.00
Spread: 2.00 (0.248%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Interim Management Statement

8 May 2013 11:00

RNS Number : 2291E
Savills PLC
08 May 2013
 



 

8 May 2013

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 20 Grosvenor Hill, Berkeley Square, London W1K 3HQ and provides the following Interim Management Statement (IMS) for the period to 8 May 2013.

 

During the first four months of the year Savills has traded as anticipated with strong growth in Asia, a robust performance from the newly combined UK businesses and a continued reduction in losses in Continental Europe. Our US business has also shown improved performance in comparison with the same period last year and Cordea Savills, the Group's investment management business, has traded in line with our expectations. As previously indicated, we expect that our trading result to date will result in a stronger first half performance than in 2012 with the full year outlook in line with our expectations.

 

To date trading across the Asia Pacific region has remained strong with substantial improvements year on year. Looking forward, as anticipated, the residential markets in Hong Kong are being significantly affected by the latest round of Government control measures implemented in March with volumes falling by circa 30%. The doubling of stamp duty on commercial transactions in Hong Kong has also reduced the aggregate value of transactions since its implementation. We anticipate that improvements in trading in other parts of the region, particularly Australia and Japan will help to mitigate the financial impact of reduced transactional volumes in Hong Kong.

 

London's attractions as an investment location remain firmly established and indeed potentially enhanced by fiscal and other control measures implemented in other markets. In the UK commercial market Savills has continued to maintain a significant share of the Prime Central London investment and leasing markets, although the shortage of supply of investment stock has become apparent. The increasing interest of overseas investors in Prime Central London assets has resulted in more domestic investors looking to opportunities in the UK's principal regional cities. Whilst it is still too early to be definitive, if this trend continues, we expect to see some improvements in our regional UK business through the coming period.

 

The Prime Residential market in central London has continued to perform strongly with year on year increases in both volume and value. Outside London, although it is early in the selling season, we have seen some improvement in the volume of activity in the traditionally stronger regional markets evidenced by improved volumes of new stock, applicants and viewings.

 

Globally, our Consultancy business has experienced double digit revenue growth with particular strengths in Planning and Development consultancy. The Property Management business has continued to deliver a solid increase in revenue.

 

Following a year of strategic changes and operational developments undertaken in 2012, Cordea Savills is now focused on further growth initiatives in Europe and Asia.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer/Martha Walsh

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEANSPEANDEEF
Date   Source Headline
14th Jan 20217:00 amRNSYear End Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights
18th Dec 20208:59 amRNSNon-executive Director changes
14th Dec 20209:45 amRNSDirector/PDMR Shareholding
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
3rd Nov 20202:26 pmRNSHolding(s) in Company
22nd Oct 20205:41 pmRNSHolding(s) in Company
13th Oct 20205:22 pmRNSDirector/PDMR Shareholding
1st Oct 202010:00 amRNSTotal Voting Rights
14th Sep 202011:05 amRNSDirector/PDMR Shareholding
2nd Sep 202010:41 amRNSHolding(s) in Company
13th Aug 20205:00 pmRNSDirector/PDMR Shareholding
6th Aug 20207:00 amRNSHalf-year Report
4th Aug 20203:22 pmRNSTotal Voting Rights
21st Jul 202010:00 amRNSBlock listing Interim Review
13th Jul 20202:15 pmRNSHolding(s) in Company
13th Jul 202012:26 pmRNSDirector/PDMR Shareholding
6th Jul 202010:13 amRNSHolding(s) in Company
6th Jul 202010:09 amRNSHolding(s) in Company
1st Jul 20204:51 pmRNSDirector/PDMR Shareholding
1st Jul 202010:00 amRNSTotal Voting Rights
30th Jun 20204:52 pmRNSDirector/PDMR Shareholding
25th Jun 202011:27 amRNSResult of AGM
25th Jun 20207:00 amRNSAGM Statement
11th Jun 202011:29 amRNSDirector/PDMR Shareholding
5th Jun 20201:03 pmRNSDirectors Remuneration Policy - Clarification
5th Jun 202012:42 pmRNSDirectors Remuneration Policy - Clarification
1st Jun 20207:00 amRNSTotal Voting Rights
12th May 202012:01 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTotal Voting Rights
30th Apr 202012:15 pmRNSDisclosure of rights attached to equity shares
28th Apr 20203:53 pmRNSDirector/PDMR Shareholding
16th Apr 202011:56 amRNSDirector/PDMR Shareholding
6th Apr 202012:37 pmRNSAnnual Report and AGM Notice
1st Apr 20207:00 amRNS2020 AGM & 2019 final and supplemental dividends
1st Apr 20207:00 amRNSTotal Voting Rights
20th Mar 20205:33 pmRNSDirector/PDMR Shareholding
20th Mar 20201:40 pmRNSDirector/PDMR Shareholding
13th Mar 20201:43 pmRNSDirector/PDMR Shareholding
12th Mar 20207:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results
11th Mar 20201:12 pmRNSDirector/PDMR Shareholding
26th Feb 202012:58 pmRNSHolding(s) in Company
17th Feb 20203:29 pmRNSBlock listing Interim Review
11th Feb 20205:00 pmRNSDirector/PDMR Shareholding
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20209:00 amRNSBlock listing Interim Review
13th Jan 202012:04 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSYear end Trading Update
7th Jan 202010:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.